Page 6 - Cell Cycle News Today

The process of metastasis is when cancer cells gain motility and spread to other sites of the body. Because this is one of the main causes of cancer-related deaths, researchers have aimed to develop therapeutic strategies that can block metastasis.

A new study from North Carolina State University shows a reproducible way of studying cellular communication among varied types of plant cells by "bioprinting" these cells via a 3D printer.

The Oklahoma Medical Research Foundation has named Dr. Elizabeth Finn as an assistant member in the Cell Cycle and Cancer Biology Research Program.

A recent study hypothesized that ALT might compromise telomere integrity if not restricted appropriately.

Local foundation hosts an event to shed light on sickle cell disease, starting at 8 a.m. at Shelby Park in East Nashville at the River View Shelter.

Rapamycin, also known as sirolimus, is an immunosuppressant drug that was approved by the Food and Drug Administration (FDA) in 1999.

Researchers have deciphered a signaling cascade through which inborn errors in metabolism provoke deadly neuroendocrine tumors in the adrenal glands.

The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.

Scientists from China have recently deciphered the genetic network and biological mechanisms associated with COVID-19 myocarditis using bioinformatic methods.

In a recent study under review at the Scientific Reports journal and currently posted to the Research Square* preprint server, researchers synthesized and evaluated the antitumoral (against several cancer cell lines) and antiviral [against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] properties of 3-spiro-indolin-2-ones.